nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allergic sensitization impairs lung resident memory CD8 T-cell response and virus clearance
|
Agrawal, Komal |
|
|
150 |
6 |
p. 1415-1426.e9 |
artikel |
2 |
Allosteric inhibition of SHP2 rescues functional T-cell abnormalities in SAP deficiency
|
Panchal, Neelam |
|
|
150 |
6 |
p. 1507-1516.e7 |
artikel |
3 |
An update on anaphylaxis and urticaria
|
Worm, Margitta |
|
|
150 |
6 |
p. 1265-1278 |
artikel |
4 |
Brief Overview of This Month's JACI
|
|
|
|
150 |
6 |
p. A1-A2 |
artikel |
5 |
Chronic spontaneous urticaria guidelines: What is new?
|
Zuberbier, Torsten |
|
|
150 |
6 |
p. 1249-1255 |
artikel |
6 |
CME Calendar-AAAAI
|
|
|
|
150 |
6 |
p. A49-A50 |
artikel |
7 |
Concise update on the pathogenesis of chronic spontaneous urticaria (CSU)
|
Hide, Michihiro |
|
|
150 |
6 |
p. 1403-1404 |
artikel |
8 |
Cover 1
|
|
|
|
150 |
6 |
p. OFC |
artikel |
9 |
Differentiating histaminergic and nonhistaminergic angioedema with or without urticaria
|
Farkas, Henriette |
|
|
150 |
6 |
p. 1405-1409 |
artikel |
10 |
Distinct transcriptomic and metabolomic profiles characterize NSAID-induced urticaria/angioedema patients undergoing aspirin desensitization
|
Tay, Sen Hee |
|
|
150 |
6 |
p. 1486-1497 |
artikel |
11 |
Do regional geography and race influence management of chronic spontaneous urticaria?
|
Mosnaim, Giselle S. |
|
|
150 |
6 |
p. 1260-1264.e7 |
artikel |
12 |
Drug allergy: A 2022 practice parameter update
|
Khan, David A. |
|
|
150 |
6 |
p. 1333-1393 |
artikel |
13 |
Editorial Board
|
|
|
|
150 |
6 |
p. A29 |
artikel |
14 |
Erratum
|
|
|
|
150 |
6 |
p. 1565 |
artikel |
15 |
FOXI3 haploinsufficiency contributes to low T-cell receptor excision circles and T-cell lymphopenia
|
Ghosh, Rajarshi |
|
|
150 |
6 |
p. 1556-1562 |
artikel |
16 |
Human IgE mAbs identify major antigens of parasitic worm infection
|
Hadadianpour, Azadeh |
|
|
150 |
6 |
p. 1525-1533 |
artikel |
17 |
Identification of major human IgE-inducing parasite antigens: A path to therapeutic approaches?
|
Dombrowicz, David |
|
|
150 |
6 |
p. 1412-1414 |
artikel |
18 |
IL-33 antagonism does not improve chronic atopic dermatitis: What can we learn?
|
Schuler IV, Charles F. |
|
|
150 |
6 |
p. 1410-1411 |
artikel |
19 |
Immunotherapy: State-of-the-art review of therapies and theratypes
|
Agache, Ioana |
|
|
150 |
6 |
p. 1279-1288 |
artikel |
20 |
Information for Readers
|
|
|
|
150 |
6 |
p. A30 |
artikel |
21 |
Mast cell chymase regulates extracellular matrix remodeling-related events in primary human small airway epithelial cells
|
Zhao, Xinran O. |
|
|
150 |
6 |
p. 1534-1544 |
artikel |
22 |
MicroRNA-21-5p promotes mucosal type 2 inflammation via regulating GLP1R/IL-33 signaling in chronic rhinosinusitis with nasal polyps
|
Luan, Ge |
|
|
150 |
6 |
p. 1460-1475 |
artikel |
23 |
New insights in systemic lupus erythematosus: From regulatory T cells to CAR-T-cell strategies
|
Doglio, Matteo |
|
|
150 |
6 |
p. 1289-1301 |
artikel |
24 |
News beyond our pages
|
Rothenberg, Marc E. |
|
|
150 |
6 |
p. 1401-1402 |
artikel |
25 |
News &Notes
|
|
|
|
150 |
6 |
p. A42-A43 |
artikel |
26 |
Novel biologics for treatment of chronic spontaneous urticaria
|
Casale, Thomas B. |
|
|
150 |
6 |
p. 1256-1259 |
artikel |
27 |
Periostin: Only a tissue biomarker in eosinophilic esophagitis assessment?
|
Urbani, Sara |
|
|
150 |
6 |
p. 1563 |
artikel |
28 |
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis
|
Maurer, Marcus |
|
|
150 |
6 |
p. 1517-1524 |
artikel |
29 |
REGN1908/1909 prevented cat allergen–induced early asthmatic responses in an environmental exposure unit
|
de Blay, Frederic J. |
|
|
150 |
6 |
p. 1437-1446 |
artikel |
30 |
Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria
|
Maurer, Marcus |
|
|
150 |
6 |
p. 1498-1506.e2 |
artikel |
31 |
Reply
|
Muir, Amanda B. |
|
|
150 |
6 |
p. 1563-1564 |
artikel |
32 |
RNF213-associated urticarial lesions with hypercytokinemia
|
Louvrier, Camille |
|
|
150 |
6 |
p. 1545-1555 |
artikel |
33 |
Scientific journey to the first FDA-approved drug for eosinophilic esophagitis
|
Rothenberg, Marc E. |
|
|
150 |
6 |
p. 1325-1332 |
artikel |
34 |
Table of Contents
|
|
|
|
150 |
6 |
p. A3, A9-A12, A21-A23 |
artikel |
35 |
Targeting CD22 on memory B cells to induce tolerance to peanut allergens
|
Hardy, LaKeya C. |
|
|
150 |
6 |
p. 1476-1485.e4 |
artikel |
36 |
The Editors’ Choice
|
|
|
|
150 |
6 |
p. 1394-1400 |
artikel |
37 |
The lung in inborn errors of immunity: From clinical disease patterns to molecular pathogenesis
|
Gutierrez, Maria J. |
|
|
150 |
6 |
p. 1314-1324 |
artikel |
38 |
Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis
|
Bognanni, Antonio |
|
|
150 |
6 |
p. 1447-1459 |
artikel |
39 |
TSLP, IL-33, and IL-25: Not just for allergy and helminth infection
|
Stanbery, Alison G. |
|
|
150 |
6 |
p. 1302-1313 |
artikel |
40 |
Understanding racial disparities in childhood asthma using individual- and neighborhood-level risk factors
|
Correa-Agudelo, Esteban |
|
|
150 |
6 |
p. 1427-1436.e5 |
artikel |